- Recommendation ID
- NG80/11
- Question
Increasing the dose of ICS within a personalised self-management programme for children and young people - For children and young people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when asthma control has deteriorated compared with using the usual dose in a self-management programme?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Asthma: diagnosis, monitoring and chronic asthma management
- Number
- NG80
- Date issued
- November 2017
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/03/2021 |